Free Trial
OTC:ZOMDF

Zomedica (ZOMDF) Stock Price, News & Analysis

Zomedica logo
$0.04 0.00 (-7.43%)
As of 08/8/2025 03:58 PM Eastern

About Zomedica Stock (OTC:ZOMDF)

Key Stats

Today's Range
$0.04
$0.04
50-Day Range
$0.04
$0.05
52-Week Range
$0.02
$0.16
Volume
1.37 million shs
Average Volume
4.14 million shs
Market Capitalization
$36.65 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Zomedica Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
17th Percentile Overall Score

ZOMDF MarketRank™: 

Zomedica scored higher than 17% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Zomedica.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Zomedica is -0.34, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Zomedica is -0.34, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

    0.05% of the outstanding shares of Zomedica have been sold short.
  • Short Interest Ratio / Days to Cover

    Zomedica has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Zomedica has recently decreased by 37.50%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Zomedica does not currently pay a dividend.

  • Dividend Growth

    Zomedica does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.05% of the outstanding shares of Zomedica have been sold short.
  • Short Interest Ratio / Days to Cover

    Zomedica has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Zomedica has recently decreased by 37.50%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Zomedica has a news sentiment score of 0.18. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Manufacturing companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Zomedica this week, compared to 0 articles on an average week.
  • Search Interest

    1 people have searched for ZOMDF on MarketBeat in the last 30 days.
  • MarketBeat Follows

    2 people have added Zomedica to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Zomedica insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 5.58% of the stock of Zomedica is held by insiders.

  • Percentage Held by Institutions

    Only 8.95% of the stock of Zomedica is held by institutions.

  • Read more about Zomedica's insider trading history.
Receive ZOMDF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zomedica and its competitors with MarketBeat's FREE daily newsletter.

ZOMDF Stock News Headlines

The Coin That Could Define Trump’s Crypto Presidency
When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed. While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.”
Zomedica Corp. (ZOMDF)
See More Headlines

ZOMDF Stock Analysis - Frequently Asked Questions

Zomedica's stock was trading at $0.1229 at the beginning of the year. Since then, ZOMDF shares have decreased by 69.6% and is now trading at $0.0374.

Shares of ZOMDF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTC
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
OTC:ZOMDF
Previous Symbol
OTC:ZOMDF
CIK
1684144
Fax
N/A
Employees
50
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
979,950,000
Free Float
N/A
Market Cap
$36.65 million
Optionable
N/A
Beta
1.60

Social Links

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (OTC:ZOMDF) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners